Literature DB >> 10404312

The treatment of Legionnaires' disease.

M Dedicoat1, P Venkatesan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404312     DOI: 10.1093/jac/43.6.747

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.

Authors:  M T García; C Pelaz; M J Giménez; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Characterization and quantitation of a novel β-lactamase gene found in a wastewater treatment facility and the surrounding coastal ecosystem.

Authors:  Miguel I Uyaguari; Erin B Fichot; Geoffrey I Scott; R Sean Norman
Journal:  Appl Environ Microbiol       Date:  2011-09-30       Impact factor: 4.792

Review 3.  Treatment of Legionnaires' disease.

Authors:  Guy W Amsden
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Legionnaires' disease - Results of a multicentre Canadian study.

Authors:  Thomas J Marrie; Emidio De Carolis; Victor L Yu; Janet Stout
Journal:  Can J Infect Dis       Date:  2003-05

5.  Clinical features and predictors of mortality in admitted patients with community- and hospital-acquired legionellosis: a Danish historical cohort study.

Authors:  Sanne Jespersen; Ole S Søgaard; Henrik C Schønheyder; Michael J Fine; Lars Ostergaard
Journal:  BMC Infect Dis       Date:  2010-05-21       Impact factor: 3.090

6.  Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.

Authors:  Annie S Jasper; Jackson S Musuuza; Jessica S Tischendorf; Vanessa W Stevens; Shantini D Gamage; Fauzia Osman; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 20.999

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.